BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vootukuru N, Vasudevan A. Approach to loss of response to advanced therapies in inflammatory bowel disease. World J Gastroenterol 2024; 30(22): 2902-2919 [PMID: 38947290 DOI: 10.3748/wjg.v30.i22.2902]
URL: https://www.wjgnet.com/1948-5190/full/v30/i22/2902.htm
Number Citing Articles
1
Cristina Rubín de Célix, Elena Ricart, M. Dolores Martín‐Arranz, Ruth de Francisco, Francisco Javier García‐Alonso, Francisco Mesonero, Fernando Gomollón, Luisa de Castro, Laura Ramos, Santiago García‐López, Lara Arias, Miriam Mañosa, Eva Iglesias, Xavier Calvet, Carles Suria Bolufer, María José Casanova, José Lázaro Pérez‐Calle, Antonio Giordano, Mónica Sierra‐Ausín, Isabel Vera, Mercè Navarro‐Llavat, Rufo Lorente, Marta Piqueras, Montserrat Rivero, Jordi Guardiola, María Esteve, Ana Fuentes Coronel, Iago Rodríguez‐Lago, Ángel Ponferrada‐Díaz, Yolanda Ber, Carlos Tardillo, Lucía Márquez, Daniel Carpio, Carlos Taxonera, Fernando Bermejo, David Busquets, Blau Camps, Ana Gutiérrez, Mariana Fe García‐Sepulcre, Manuel Barreiro‐de Acosta, Ignacio Marín‐Jiménez, José M. Huguet, Luis Ignacio Fernández‐Salazar, Jordina Jaó, Cristina Rodríguez‐Gutiérrez, Carlos Martínez‐Flores, Luis Bujanda, Alfredo J. Lucendo, Eva Sesé, Pilar Robledo Andrés, Daniel Ginard, Pablo Vega, Joan Riera, Ramón Pajares, Manuel Van Domselaar, Pedro Almela, Teresa Martínez Pérez, Carmen Muñoz‐Villafranca, Pilar Varela, Federico Argüelles‐Arias, Pilar Nos, Guillermo Alcaín, Luis Hernández, Hipólito Fernández, Fernando Muñoz, Pau Gilabert, Victor Manuel Navas‐López, Patricia Ramírez de la Piscina, Lidia Buendía Sánchez, Jesús Legido Gil, Gemma Valldosera, Rosa Ana Muñoz, Santiago Frago, Eugeni Domènech, María Chaparro, Javier P. Gisbert. Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW‐IBD Study of ENEIDAAlimentary Pharmacology & Therapeutics 2025;  doi: 10.1111/apt.70312
2
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel diseaseWorld Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825
3
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
4
J. Bronsky, K. Zarubova, I. Copova, M. Durilova, D. Kazeka, M. Kubat, T. Lerchova, K. Mitrova, E. Vlckova, J. Duskova, J. Dostalikova, O. Hradsky. Association of Serum Levels of Ustekinumab, Vedolizumab, and Faecal Calprotectin in Paediatric Patients with Inflammatory Bowel Diseases: A Prospective Observational StudyPediatric Drugs 2025;  doi: 10.1007/s40272-025-00702-9
5
Marcello Imbrizi, Matheus F C Azevedo, Julio P Baima, Natália S F Queiroz, Rogério S Parra, Sandro D C Ferreira, Ligia Y Sassaki, Julio Maria F Chebli. Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practiceWorld Journal of Gastroenterology 2025; 31(29): 107745 doi: 10.3748/wjg.v31.i29.107745